Partial purification and characterization of angiotensin-converting enzyme in mouse and human skin. 1982

A Hara, and K Fukuyama, and W L Epstein

The chemical properties of skin angiotensin-converting enzyme were characterized in mouse and human. In newborn mice, dermis contained almost all activity (1.3 mU/mg), of which 30% was in the 22,000 kappa g supernatant and 70% in the pellet which could be solubilized by Triton X-100. The activity increased sharply during the first 6 weeks after the birth. By gel filtration, the enzyme in the supernatant was Mr 330,000, but the solubilized enzyme was Mr 430,000 in the presence of Triton X-100. By electrophoresis, the 2 enzyme fractions demonstrated a charge difference. The enzymes showed the same pH optima of around 8.1 and 7.7, and Km values of 2.6 and 0.11 mm for Hip-His-Leu and angiotensin I, respectively. Sensitivity to known inhibitors and heat stability of the enzymes in 2 fractions were similar. In the human, 56% of the activity in skin homogenates (1.5 mU/mg) appeared in this supernatant and 44% in the pellet. Both soluble and solubilized preparations showed enzyme activity with 2 different molecular weights, 330,000 and 430,000. The human enzymes had chemical properties similar to the mouse enzymes, but their affinity for Hip-His-Leu and angiotensin I were 1.6 and 2 times higher than those of the mouse enzymes.

UI MeSH Term Description Entries
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A Hara, and K Fukuyama, and W L Epstein
January 1970, Analytical biochemistry,
A Hara, and K Fukuyama, and W L Epstein
January 1980, Scandinavian journal of clinical and laboratory investigation,
A Hara, and K Fukuyama, and W L Epstein
November 1995, Biochemical Society transactions,
A Hara, and K Fukuyama, and W L Epstein
January 1989, Advances in experimental medicine and biology,
A Hara, and K Fukuyama, and W L Epstein
October 1986, Metabolism: clinical and experimental,
A Hara, and K Fukuyama, and W L Epstein
April 1981, The Journal of clinical investigation,
A Hara, and K Fukuyama, and W L Epstein
July 1971, Japanese circulation journal,
A Hara, and K Fukuyama, and W L Epstein
January 1991, Journal of cardiovascular pharmacology,
A Hara, and K Fukuyama, and W L Epstein
March 1988, Kidney international,
A Hara, and K Fukuyama, and W L Epstein
August 1977, Biochimica et biophysica acta,
Copied contents to your clipboard!